Keywords
synovial fluid analysis
gout
calcium pyrophosphate deposition disease
crystal arthropathy
polarized light microscopy
Categories
How to Cite
Abstract
Crystal analysis in synovial fluid (SF) is crucial for diagnosing crystal induced arthropathies which are an important cause of acute and chronic joint inflammation. Identification of crystals in synovial fluid remains a key diagnostic step in the evaluation of patients presenting with arthritis. The direct identification of crystals in synovial fluid remains the clinical reference standard for confirming gout and calcium pyrophosphate deposition disease (CPPD), while the recognition of less common particles such as basic calcium phosphate (BCP) and cholesterol crystals can also provide clinically relevant information. This review summarizes the literature from 2017 to 2026 on crystals in synovial fluid, with particular emphasis on crystal types, detection methods and their clinical relevance. It aims to provide a practical, clinician-oriented review of SF crystal analysis, highlighting crystal morphology, detection techniques, disease associations and clinical interpretation. Monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals remain the most diagnostically important. Compensated polarized light microscopy remains the gold standard for crystal identification, but it is limited by observer dependence, low crystal burden, weak birefringence and artifacts. Newer techniques, especially Raman spectroscopy and other chemistry-based approaches, are emerging as promising adjuncts. Imaging methods such as ultrasound and dual-energy CT increasingly complement aspiration-based diagnosis but do not replace synovial fluid examination, particularly when infection is a concern. Recognition of synovial fluid crystals has important clinical implications, as crystal-induced arthritis may mimic or coexist with other joint diseases, including septic arthritis. Improved diagnostic techniques and continued clinician training may enhance the accuracy and clinical utility of synovial fluid analysis. SF crystal analysis is a practical, rapid, and reliable diagnostic tool. Familiarity with crystal morphology, detection methods, and clinical implications improves diagnostic accuracy and guides therapy.
References
1. Mandl P, D’Agostino MA, Navarro-Compán V, Geßl I, Sakellariou G, Abhishek A, et al. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice. Ann Rheum Dis. 2024 Jun 1;83(6):752–9. doi:10.1136/ard-2023-224771 PubMed PMID: 38320811.
2. Berendsen D, Neogi T, Taylor WJ, Dalbeth N, Jansen TL. Crystal identification of synovial fluid aspiration by polarized light microscopy. An online test suggesting that our traditional rheumatologic competence needs renewed attention and training. Clin Rheumatol. 2017 Mar 1;36(3):641–7. doi:10.1007/s10067-016-3461-0
3. Atlas of Synovial Fluid Cytopathology | Springer Nature Link. Available from: https://link.springer.com/book/10.1007/978-94-011-3828-4
4. Unusual Findings in Synovial Fluid Analysis: A Review. Available from: https://www.annclinlabsci.org/content/47/3/253.full
5. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016 Oct 22;388(10055):2039-2052. doi: 10.1016/S0140-6736(16)00346-9.
6. Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev. 2010;233(1):218–32. doi:10.1111/j.0105-2896.2009.00860.x
7. Oliviero F, Mandell BF. Synovial fluid analysis: Relevance for daily clinical practice. Best Pract Res Clin Rheumatol. 2023 Mar 1;PART A - Practical Procedures ‘How to do’ & PART B - Vasculitis37(1):101848. doi:10.1016/j.berh.2023.101848
8. Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020 Jan 1;79(1):31–8. doi:10.1136/annrheumdis-2019-215315 PubMed PMID: 31167758.
9. Seidman AJ, Limaiem F. Synovial Fluid Analysis. In: StatPearls [Internet] [Internet]. StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537114/ PubMed PMID: 30725799.
10. Zell M, Zhang D, FitzGerald J. Diagnostic advances in synovial fluid analysis and radiographic identification for crystalline arthritis. Curr Opin Rheumatol. 2019 Mar;31(2):134-143. doi: 10.1097/BOR.0000000000000582.
11. Calcium pyrophosphate deposition disease - The Lancet Rheumatology. Available from: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00122-X/fulltext
12. Calcium Pyrophosphate Deposition Disease | New England Journal of Medicine. Available from: https://www.nejm.org/doi/full/10.1056/NEJMra1511117
13. Bernal JA, Andrés M, López-Salguero S, Jovaní V, Vela-Casasempere P, Pascual E. Agreement Among Multiple Observers on Crystal Identification by Synovial Fluid Microscopy. Arthritis Care Res. 2023;75(3):682–8. doi:10.1002/acr.24874
14. Swan A, Amer H, Dieppe P. The value of synovial fluid assays in the diagnosis of joint disease: a literature survey. Ann Rheum Dis. 2002 Jun;61(6):493–8. doi:10.1136/ard.61.6.493 PubMed PMID: 12006320; PubMed Central PMCID: PMC1754135.
15. Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, et al. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Ann Rheum Dis. 2023 Oct 1;82(10):1248–57. doi:10.1136/ard-2023-224575 PubMed PMID: 37495237.
16. Momcheva II. Increased level of C3 in synovial fluid in patients with activated osteoarthritis as a diagnostic and therapeutic target – pilot group of patients from the Rheumatology Department at UMHAT Burgas. Rheumatol Bulg. 2023 Dec 12;31(3):19–29. doi:10.35465/31.3.2023.pp19-29
17. Cowley S, McCarthy G. Diagnosis and Treatment of Calcium Pyrophosphate Deposition (CPPD) Disease: A Review. Open Access Rheumatol. 2023 Mar 22;15:33-41. doi: 10.2147/OARRR.S389664.
18. Mukerji S, Ryan P, Simmonds H, Buckley J, Birdling J. Concomitant septic and crystal arthropathy: a single-centre 10-year retrospective observational study in New Zealand. N Z Med J. 2024 Jun 21;137(1597):67–78. doi:10.26635/6965.6510 PubMed PMID: 38901050.
19. The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis | The Journal of Rheumatology. Available from: https://www.jrheum.org/content/52/1/87
20. Identification of crystals in synovial fluid - Annals of the Rheumatic Diseases. Available from: https://ard.eular.org/article/S0003-4967(24)43636-4/abstract
21. Niessink T, Jansen TL, Kleinherenbrink M, Janssen M, Otto C. Synovial fluid analysis with compensated polarization light microscopy: a physics approach to quantitative understanding of birefringence, polarization, and Maltese crosses. Clin Rheumatol. 2024 Dec 1;43(12):3597–602. doi:10.1007/s10067-024-07185-y
22. Dylewski J. Acute monoarticular arthritis caused by Maltese cross-like crystals. Can Med Assoc J. 2005 Mar 15;172(6):741–2. doi:10.1503/cmaj.045248
23. Li B, Singer N, Rosenthal A, Unal M, Haggins D, Yeni YN, et al. Chemical characterization of Maltese-cross birefringent particles in synovial fluid samples collected from symptomatic joints. Joint Bone Spine. 2018 Jul;85(4):501-503. doi: 10.1016/j.jbspin.2017.09.003.
24. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis. | Semantic Scholar. Available from: https://www.semanticscholar.org/paper/Plasma-profiles-and-dialysis-kinetics-of-oxalate-in-Marangella-Petrarulo/f0eb8826b95f816f46ce0041557e5d77287e194f
25. Rosenstock JL, Joab TMJ, DeVita MV, Yang Y, Sharma PD, Bijol V. Oxalate nephropathy: a review. Clin Kidney J. 2022 Feb;15(2):194-204. doi: 10.1093/ckj/sfab145.
26. Niessink T, Jansen TL, Janssen M, Otto C. Advances in Synovial Fluid Analysis for the Diagnosis of Crystal Arthropathies. Arthritis Care Res. 2026;78(6):788–97. doi:10.1002/acr.25698
27. Hosu CD, Moisoiu V, Stefancu A, Antonescu E, Leopold LF, Leopold N, et al. Raman spectroscopy applications in rheumatology. Lasers Med Sci. 2019 Jun 1;34(4):827–34. doi:10.1007/s10103-019-02719-2
28. Niessink T, Jansen TL, Coumans FAW, Welting TJM, Janssen M, Otto C. An objective diagnosis of gout and calcium pyrophosphate deposition disease with machine learning of Raman spectra acquired in a point-of-care setting. Rheumatol Oxf Engl. 2024 Sep 2;64(4):1791–8. doi:10.1093/rheumatology/keae472 PubMed PMID: 39222431; PubMed Central PMCID: PMC11962871.
29. Zamudio-Cuevas Y, Martínez-Nava GA, Martínez-Flores K, Ventura-Ríos L, Vazquez-Mellado J, Rodríguez-Henríquez P, et al. Synovial fluid analysis for the enhanced clinical diagnosis of crystal arthropathies in a tertiary care institution. Clin Rheumatol. 2021 Aug 1;40(8):3239–46. doi:10.1007/s10067-021-05610-0
30. Codes-Méndez H, Sainz L, Park HS, Corominas H, Diaz-Torne C. Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD Open. 2024 Apr;10(2):e004173. doi:10.1136/rmdopen-2024-004173
31. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice | Annals of the Rheumatic Diseases. Available from: https://ard.bmj.com/content/83/6/752
32. Pesante BD, Salimi M, Miller WL, Young HL, Jenkins TC, Parry JA. The Effect of Crystal Arthropathy on the Diagnostic Criteria of Native Septic Arthritis. J Am Acad Orthop Surg. 2024 Jun 1;32(12):570–5. doi:10.5435/jaaos-d-23-00857 PubMed PMID: 38652879.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Vassilia Terzieva, Mariana Ivanova, Georgi Kotov (Author)